Variant report
Variant | nsv538268 |
---|---|
Chromosome Location | chr6:62900450-62928906 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191800863 | chr6:62900468-62900469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537045115 | chr6:62900476-62900477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs555471712 | chr6:62900486-62900487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs370364710 | chr6:62900520-62900521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552501933 | chr6:62900572-62900573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183690965 | chr6:62900575-62900576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148383067 | chr6:62900582-62900583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188357499 | chr6:62900590-62900591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551082 | chr6:62900591-62900592 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs58985768 | chr6:62900603-62900604 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs141552489 | chr6:62900604-62900605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs116414700 | chr6:62900617-62900618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182285029 | chr6:62900645-62900646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557701473 | chr6:62900649-62900650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572874371 | chr6:62900657-62900658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540363587 | chr6:62900721-62900722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145638666 | chr6:62900749-62900750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573928432 | chr6:62900801-62900802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544375215 | chr6:62900818-62900819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562648145 | chr6:62900862-62900863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533218272 | chr6:62900864-62900865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552308139 | chr6:62900880-62900881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138210671 | chr6:62900900-62900901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528455989 | chr6:62900974-62900975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368197975 | chr6:62911218-62911219 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532671358 | chr6:62911226-62911227 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192809197 | chr6:62911282-62911283 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570721101 | chr6:62911347-62911348 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563119824 | chr6:62911442-62911443 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150730449 | chr6:62911473-62911474 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530329763 | chr6:62911527-62911528 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541058008 | chr6:62911549-62911550 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184671607 | chr6:62911560-62911561 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139024475 | chr6:62911565-62911566 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187570241 | chr6:62911616-62911617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566125496 | chr6:62911692-62911693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536462396 | chr6:62911718-62911719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555119715 | chr6:62911739-62911740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs71568790 | chr6:62911772-62911773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs116192781 | chr6:62911773-62911774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192514956 | chr6:62911780-62911781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs149913416 | chr6:62911781-62911782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528043129 | chr6:62911792-62911793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs141309842 | chr6:62921604-62921605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs150342263 | chr6:62921668-62921669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567689 | chr6:62921711-62921712 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs528684364 | chr6:62921761-62921762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556970314 | chr6:62921776-62921777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs576360114 | chr6:62921802-62921803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575224817 | chr6:62921812-62921813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung cancer | 19547694 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 19492091 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:62899400-62900600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr6:62899800-62901000 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr6:62911200-62911600 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr6:62911200-62911800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr6:62921600-62929600 | Weak transcription | Primary B cells from cord blood | blood |
6 | chr6:62922800-62923200 | Active TSS | A549 | lung |
7 | chr6:62923000-62923400 | Enhancers | Hela-S3 | cervix |
8 | chr6:62923200-62923400 | Flanking Active TSS | A549 | lung |
9 | chr6:62925200-62925400 | Active TSS | Ovary | ovary |